Crescent Biopharma files underwriting agreement for share offering
Crescent Biopharma Inc. entered an underwriting agreement with Jefferies LLC and TD Securities to sell 8,094,793 shares and relevant warrants. This capital raise allows the Cayman Islands company to proceed with its planned public offering.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day